CHICAGO HIGHLIGHTS 2024 – MELANOMA ROUNDTABLE DISCUSSION: Advances in first line therapy for advanced melanoma
OR
Chair
Dr. Vanessa Bernstein
Panelists
Prof. Caroline Robert
Dr. Marcus Butler
Studies/trials discussed:
- Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib (EBIN)
